News | Stethoscopes | October 26, 2018

Eko, Mayo Clinic Collaborating on AI-Based Heart Disease Detection

Eko’s software and smart digital stethoscope combined with Mayo’s vast data and tech aims to help physicians with earlier detection of life-threatening conditions

Eko, Mayo Clinic Collaborating on AI-Based Heart Disease Detection

October 26, 2018 — Eko, creators of a machine learning-based heart and lung monitoring platform, announced a collaboration with Mayo Clinic to develop a data-driven technology to help physicians detect potentially dangerous heart diseases that may otherwise be missed. The two entities will work together to develop and commercialize a machine learning-based algorithm with a smart digital stethoscope that screens patients for the presence of a low ejection fraction. Once identified, evidence-based treatments are available that prolong life and reduce the risk of symptoms.

The technology leverages the Mayo Clinic’s vast cardiovascular database and their expertise in medical artificial intelligence (AI) and heart disease screening, and combines it with Eko’s cardiac monitoring platform. Traditionally, ejection fraction is measured by imaging techniques such as echocardiography, which is a powerful but expensive and time-consuming test that is less accessible to most people in North America and around the world than a doctor with a stethoscope. With this algorithm, Eko can help screen patients in seconds in the doctor’s office. Because the Eko tool can be used by any healthcare provider, it may detect heart function abnormalities earlier and in patients who might not otherwise be screened for heart disease.

“With this collaboration we hope to transform the stethoscope in the pocket of every physician and nurse from a hand tool to a power tool,” said Paul Friedman, M.D., chair of cardiovascular medicine at Mayo Clinic in Rochester, Minn. “The community practitioner performing high school sports physicals and the surgeon about to operate may be able to seamlessly tap the knowledge of an experienced cardiologist to determine if a weak heart pump is present simply by putting a stethoscope on a person’s chest for a few seconds.”

Eko aims to gain U.S. Food and Drug Administration (FDA) approval for the technology after running clinical studies with Mayo Clinic to demonstrate the safety and effectiveness of the algorithms for in-clinic screening.

Mayo Clinic and Friedman have financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

For more information: www.ekodevices.com

Related Content

FDA Proposes New Review Framework for AI-based Medical Devices
News | Artificial Intelligence | April 02, 2019 | Jeff Zagoudis, Associate Editor
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., announced Tuesday the agency is pursuing a...
New Consensus Document Explores Ethical Use of AI in Radiology
News | Artificial Intelligence | March 05, 2019 | Jeff Zagoudis, Associate Editor
The American College of Radiology (ACR) is one of seven professional societies behind a new consensus document on the...
RSNA Offers First U.S. Spotlight Course on Artificial Intelligence
News | Artificial Intelligence | March 05, 2019
The Radiological Society of North America (RSNA) announced an expansion of its artificial intelligence (AI) education...
ACC Future Hub

Presenter delivers pitch at last year’s ACC Future Hub. This year during ACC.19, entrepreneurs will pitch software and hardware specific to cardiology in two categories– artificial intelligence and digitally enabled medical devices. (Image courtesy of ACC)

Feature | Artificial Intelligence | March 01, 2019 | By Greg Freiherr
Entrepreneurs to pitch innovative ideas at ACC
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15...
Medical Imaging AI Fundings Tops $1.2 Billion Worldwide
News | Artificial Intelligence | February 04, 2019
In 2018, capital investment in companies developing artificial intelligence (AI)-enabled medical image analysis...
Siemens Healthineers Debuts AI-Rad Companion Chest CT
News | Artificial Intelligence | January 25, 2019
January 25, 2019 — Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad
Artificial Intelligence in medical imaging was the top trend and buzz at RSNA 2018.

Artificial intelligence in medical imaging was the major buzz at RSNA 2018. The expo floor had a dedicated area just to highlight artificial intelligence software for medical imaging. More than 150 vendors on the expo floor were showing software using some level of AI or deep learning. 

Feature | Artificial Intelligence | January 17, 2019 | Dave Fornell, Editor
Artificial intelligence (AI) was by far the hottest trend discussed in sessions and across the expo floor at the worl
Overlay Init